<DOC>
	<DOC>NCT00924248</DOC>
	<brief_summary>The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice</brief_summary>
	<brief_title>Primovist Regulatory Post Marketing Surveillance (PMS)</brief_title>
	<detailed_description />
	<criteria>Patient who take Primovist for liver MRI Patients who belong to the contraindication on the product label</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Liver MRI</keyword>
</DOC>